Picard Medical, Inc. Class Action: The Gross Law Firm Reminds Picard Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 3, 2026

Core Viewpoint - The Gross Law Firm is notifying shareholders of Picard Medical, Inc. regarding a class action lawsuit due to allegations of misleading statements and fraudulent activities during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from September 2, 2025, to October 31, 2025, Picard Medical was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [3]. - It is claimed that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [3]. - The public statements and risk disclosures made by Picard Medical allegedly omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [3]. - As a result of these actions, the defendants' positive statements about the company's business and prospects were deemed materially misleading and lacked a reasonable basis [3]. Group 2: Class Action Details - Shareholders who purchased shares of PMI during the specified class period are encouraged to register for the class action, with a deadline set for April 3, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. - There is no cost or obligation for shareholders to participate in this case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements or omissions that led to artificial stock price inflation [5].